|
Market Closed -
London S.E.
16:30:00 01/09/2026 BST
|
5-day change | 1st Jan Change | ||
| 64.37 EUR | 0.00% |
|
-2.73% | -16.08% |
| 09-01 | Stocks fall as borrowing costs hit 28-year high | AN |
| 09-01 | Reckitt Benckiser welcomes Mead Johnson infant formula trial verdict | AN |
Main competitors
| Consensus | Analysts' target price evolution (4 months) | Analysts' recommendations evolution (4 months) | Financial estimates divergence | Analysts' Target price divergence | Average Target P. | Objective/dr gap | Nbr of analysts | ||
|---|---|---|---|---|---|---|---|---|---|
| 88.36 | +12.11% | 22 | |||||||
| 69.13 | +11.37% | 23 | |||||||
| 80.02 | +24.49% | 22 | |||||||
| 78.7 | -3.19% | 10 | |||||||
| 205.52 | +16.64% | 21 | |||||||
| 6,103.57 | +12.99% | 14 | |||||||
| 25.09 | -2.27% | 17 | |||||||
| 37.56 | -8.85% | 18 | |||||||
| 141.22 | +21.52% | 9 | |||||||
| 29.7 | +11.91% | 5 | |||||||
| 18.41 | -10.28% | 18 | |||||||
| 3.013 | -0.18% | 11 | |||||||
| 97.25 | +15.77% | 12 | |||||||
| 60.62 | +11.8% | 13 | |||||||
| 141.44 | +7.84% | 16 | |||||||
| 83.21 | +9.2% | 12 | |||||||
| 57.67 | +17.69% | 16 | |||||||
| Average | 430.62 | +8.74% | 15 | ||||||
| Weighted average by Cap. | 363.55 | +10.36% | 18 |
- Stock Market
- Stocks
- BN Stock
- 0KFX Stock
- Sector Danone
- Sector consensus
Select your edition
All financial news and data tailored to specific country editions
















